🇺🇸 FDA
Pipeline program

Albuterol sulfate (ABS)

ABS-COPD-30065

Phase 3 small_molecule completed

Quick answer

Albuterol sulfate (ABS) for Chronic Obstructive Pulmonary Disease is a Phase 3 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Chronic Obstructive Pulmonary Disease
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials